Breathing workouts show promise for elderly COPD patients
NCT ID NCT07204431
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a respiratory physiotherapy program using PowerBreathe and PEP Therosold devices can improve lung function in elderly patients with chronic obstructive pulmonary disease (COPD). Sixty participants over age 65 were split into two groups to compare different breathing exercise protocols. Researchers measured changes in breathing strength and lung capacity using ultrasound and spirometry.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- PowerBreathe and PEP Therosold devices
- What this could lead to
- If effective, this could point toward a simple, drug-free way to help elderly COPD patients breathe easier and improve their lung function.
- What could go wrong
- This is a small, completed trial with only 60 participants. The results may not apply to all COPD patients, and the benefits might be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 to 110 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients diagnosed with chronic obstructive disease. * Patients older than 65 years. * Patients under age. * Patients with cognitive ability to perform spirometry. * Patients with physical ability to perform spirometry. Exclusion Criteria: * Patients without functional limitations in the respiratory system. * Patients under 65 years of age. * Patients with no cognitive ability to perform spirometry. * Patients without physical ability to perform spirometry.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universidad Pontificia de Salamanca
Salamanca, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a COPD flare stun the heart? study watches for hidden strain
- Can better training get doctors to talk about what matters most to dying veterans?
- Can an injected antibody calm inflamed lungs and cut COPD flare-ups?
- Detailed lung scans could map COPD damage more precisely
- Can AI help nurses guide At-Risk seniors to better care and lower costs?
- Fine-Mist inhalers aim to reach deep lungs in COPD